Search

Brian McElligott highlights the key IP considerations which should be planned for when devising a health app.

Mason Hayes & Curan present a helpful overview of key points to keep on top of after launching a health app.

Reinhold Cohn Group partner David Gilat explains why patent costs continue to be a key concern for clients.

Reinhold Cohn Group partner David Gilat shares which patterns trends he is following in 2020 and why, amidst urgent issues such as the COVID-19 pandemic, patent systems play a pivotal role.

David Gilat explains why enforcing process and product patents in the food industry is particularly challenging.

Gareth Jones, Vice President of IP at BenevolentAI discusses the implications of the convergence between tech and pharma for in-house IP teams.

Vice President of IP at BenevolentAI explores the relationship between data licensing and AI in the life science sector.

Vice President of IP at BenevolentAI, talks to IAM about the convergence between tech and pharma and what this means for IP strategies in the life sciences.

Gareth Jones, Vice President of IP at BenevolentAI tells IAM life sciences reporter, Adam Houldsworth what role AI could play in the life sciences over the next 5-10 years.

Patent experts shed light on some of the ongoing challenges in the industry.